Cynosure Group’s Labcorp LH Stock Holding History

Cynosure Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,747	Closed	-$438K	–	345
2025 Q4	$438K	Buy	+1,747	New	+$464K	0.04%	289

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cynosure Group's LH Position: Q1 2026 in Review

Cynosure Group sold out of Labcorp (LH) in Q1 2026, closing a stake of 1,747 shares — an estimated $438K sold.

Cynosure Group first reported a position in LH in Q4 2025 and held it in 1 quarter. The position peaked at $438K in Q4 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Cynosure Group reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
Cynosure Group sold 1,747 Labcorp shares in Q1 2026, an estimated $438K.
Cynosure Group first reported a position in Labcorp in Q4 2025 and held it in 1 quarter.
Cynosure Group's Labcorp position peaked at $438K in Q4 2025.
1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.